Professor of Medical Oncology, University of North Carolina School of Medicine
Hematology
Dr. Hyman B. Muss, MD
|
|
Give Review
Hyman B. Muss, MD works in the field of Hematology. He studied medicine at State University of New York Downstate Medical Center College of Medicine. He over the years received 6 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Meaningful Use Stage 1 Certification", "Fellow (FASCO)", "Redbook Magazine: Top Breast Cancer Doctors" and "Whos Who in Medicine and Healthcare". Hyman Muss is a published doctor and has 99 publications published. The lastest was: 'The effect of atorvastatin on breast cancer biomarkers in high-risk women.' Hyman B. Muss accepts Medicare.
Publications
- Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary St...
- Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and Systematic review.
- Occupational Therapy for Adults With Cancer: Why It Matters.
- The effect of atorvastatin on breast Cancer biomarkers in high-risk women.
- Breast Cancer in Women Older Than 80 Years.
- Approach and Management of Breast Cancer in the Elderly.
- Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.
- Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: A Systematic review and meta-analysis.
- Use of ED and hospital services for patients with Acute leukemia after induction therapy: One year follow-up.
- Geriatric Assessment-Identified Deficits in Older Cancer Patients With Normal Performance Status.
- Geriatric assessment in surgical oncology: a Systematic review.
- Generalizability of trial results to elderly Medicare patients with advanced solid Tumors (Alliance 70802).
- Geriatric assessment as an aide to understanding falls in older adults with Cancer.
- The prevalence of potentially modifiable functional deficits and the subsequent use of occupational and physical therapy by older adults with Cancer.
- Predicting participation in meaningful activity for older adults with Cancer.
- Infection risk in breast Cancer patients treated with trastuzumab: a systematic review and meta-analysis.
- Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 ...
- Age-Specific Changes in Intrinsic Breast Cancer Subtypes: A Focus on Older Women.
- Breast Cancer and aging: results of the U13 conference breast Cancer panel.
- Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast Cancer survivors: CALGB/Alliance 369901.
- Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB...
- Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901.
- African American Cancer Survivors: Do Cultural Factors Influence Symptom Distress?
- Endocrine therapy initiation among Medicaid-insured breast Cancer survivors with hormone receptor-positive tumors.
- Adjuvant Chemotherapy in Older Women With Breast Cancer: Who and What?
- Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast Cancer.
- Feasibility of geriatric assessment in community oncology clinics.
- Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802).
- Quality of life changes during the pre- to postdiagnosis period and treatment-related recovery time in older women with breast Cancer.
- Preoperative Breast MRI and surgical outcomes in elderly women with invasive ductal and lobular carcinoma: a population-based study.
- Managing metastatic human epidermal growth factor receptor 2 (HER2)-positive breast Cancer in the older patient.
- Sarcopenia as a Predictor for Complications and Survival Following Radical Cystectomy.
- Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast Cancer survivors on aromatase inhibitor therapy.
- Reply to P.G. Tsoutou et al, O. Kaidar-Person et al, and A. Courdi et al.
- A planned, prospective comparison of short-term quality of life outcomes among older patients with breast Cancer treated with standard chemotherapy in a randomized cli...
- Initiation of aspirin therapy modulates angiogenic protein levels in women with breast Cancer receiving tamoxifen therapy.
- The role of adjuvant radiation treatment in older women with early breast Cancer.
- Challenges in the treatment of older breast Cancer patients.
- Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker.
- Psychosocial predictors of depression among older African American patients with Cancer.
- Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343.
- Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.
- Impact of premenopausal status at breast Cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.
- Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update.
- Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast Cancer in women with zero to three pos...
- Adjuvant therapy of breast Cancer in women 70 years of age and older: tough decisions, high stakes.
- Treatment of metastatic breast Cancer in women aged 65 years and older.
- Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An Underused Lifesaving Treatment.
- Cardiopulmonary Function and Age-Related Decline Across the Breast Cancer Survivorship Continuum.
- Older Women With Breast Cancer: Slow Progress, Great Opportunity, Now Is the Time.
- Symptom Management in Metastatic Breast Cancer.
- Implementing a geriatric assessment in cooperative group clinical Cancer trials: CALGB 360401.
- Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and Leukemia group B 49907.
- Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast Cancer.
- Coming of age: breast Cancer in seniors.
- Discrepancy between preference and actual adjuvant therapy for breast Cancer.
- Recent advances: adjuvant therapy for older women with breast Cancer.
- Adjuvant chemotherapy of breast Cancer in the older patient.
- Case records of the Massachusetts General Hospital. Case 15-2010. An 85-year-old woman with mammographically detected early breast Cancer.
- Cancer in the oldest old: making better treatment decisions.
- A question of duration: do patients with early-stage breast Cancer need more than five years of adjuvant endocrine therapy?
- Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research...
- Extended adjuvant endocrine therapy in breast Cancer: current status and future directions.
- Tamoxifen and aromatase inhibitors differentially affect vascular endothelial growth factor and endostatin levels in women with breast Cancer.
- Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast Cancer: stud...
- Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast Cancer who complete 5 years of tamoxifen.
- Efficacy, toxicity, and quality of life in older women with early-stage breast Cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup...
- Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast Cancer.
- Management of the frail elderly with breast Cancer.
- Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapse in women with early stage, hormone receptor-positive Breast canc...
- Adjuvant therapy in the elderly: making the right decision.
- Phase I/II trial of adjuvant dose-dense docetaxel/epirubicin/cyclophosphamide (TEC) in stage II and III breast Cancer.
- Targeted therapy for metastatic breast Cancer.
- Managing early-stage breast Cancer in your older patients.
- The cancer and Leukemia group B cancer in the elderly committee: addressing a major cancer need.
- Inadvertent use of aromatase inhibitors in patients with breast Cancer with residual ovarian function: cases and lessons.
- Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast Cancer.
- Adjuvant chemotherapy in the elderly: whom to treat, what regimen?
- Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast Cancer taking ta...
- Optimizing adjuvant chemotherapy in early-stage breast Cancer.
- Update in medical oncology for older patients: focus on breast Cancer: management of early breast Cancer.
- Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.
- Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast Cancer: updated findings from NCIC CTG MA.17.
- Byrl James Kennedy, MD.
- Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast Cancer after moderately emetogenic chemo...
- Improving accrual of older persons to Cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.
- The influence of aging on the early detection, diagnosis, and treatment of breast Cancer.
- Selecting adjuvant endocrine therapy for breast Cancer.
- Breast Cancer in older patients.
- A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast Cancer.
- Optimizing the use of anthracyclines in the adjuvant treatment of early-stage breast Cancer.
- Paris and New York: more in common than you think!
- Diagnosis and treatment of breast Cancer in the elderly.
- Barriers to clinical trial participation by older women with breast Cancer.
- Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-po...
- Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primar...
- New Hormones for Advanced Breast Cancer.
- Approach to the Older Patient with Stage II/III Colorectal Cancer.
Schools
SUNY Downstate Medical Center College Of Medicine
Peter Bent Brigham Hospital
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Options PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Meaningful Use Stage 1 Certification
- Fellow (FASCO)
- Redbook Magazine: Top Breast Cancer Doctors
- Whos Who in Medicine and Healthcare
Education
-
Brigham and Women's Hospital -
Boston Children's Hospital -
State University of New York Downstate Medical Center College of Medicine
Hospital
-
University of North Carolina Hospitals
Drug Facts
| NPI NUMBER | 1770665580 | |
| NPPES Provider LastName | MUSS | |
| NPPES Provider FirstName | HYMAN | |
| NPPES Provider ZIPCode | 275162539 | |
| NPPES Provider State | NC | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 308.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770665580 |
| Last Name Of The Provider | MUSS |
| First Name Of The Provider | HYMAN |
| View All |
Similar Doctors
|
|
Dr. Samuel A. Merrill, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerhild R. Bjornson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven Ades, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emiliano N. Mugnaini, MD |
|
|
Dr. Chris E. Holmes, MD |
|
|
Dr. Edmund Folefac, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard F. Branda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marie E. Wood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julian R. Sprague, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie J. Olin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelli M. Clark, MD |